Product Name: CDK10 (193-199) pT196
Product Number: PE-04AJI90
Size: | 200 µg | | Price: | 32.00 |
| 1 mg | | $US | 63.00 |
| 5 mg | | | 137.00 |
Peptide Name: CDK10 (193-199) pT196
Product Use: Services as a blocking peptide for use with the CDK10-pT196 rabbit polyclonal antibody (Cat. No.: AB-PK564) that is also available from Kinexus. This phosphopeptide may also be useful as a substrate for screening the phosphatase activity of protein phosphatases. The peptide sequence is located in the protein kinase catalytic domain activation T-loop between subdomains VII and VIII. T196 phosphorylation stimulates phosphotransferase activity.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: KPM-pT-PKV
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: βAla-Cys
Peptide Modifications Other: Phosphorylated
Peptide Molecular Mass Calculated: 1053.2 Da
Peptide Purity Percent after Synthesis and Purification: >80
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
Storage Stability: solutions form dimers
Related Product 1: CDK10 - pT196 phosphosite-specific antibody (Cat. No.: AB-PK564) Scientific Background: CDK10 (PISSLRE) is a protein-serine/threonine kinase of the CMGC group and CDK family. It is a protein kinase that mediates phosphorylation and degradation of ETS2 (a transcription factor). CDK10 appears to be a tumour requiring protein (TRP). It displays one of the lowest rates of mutation in human tumours. The near absence of reported somatic mutations in this protein indicates that it may function as a tumour requiring protein (TRP) in many human tumours.